
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
Hong‐Yi Zheng, Mi Zhang, Cuixian Yang, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 5, pp. 541-543
Open Access | Times Cited: 951
Hong‐Yi Zheng, Mi Zhang, Cuixian Yang, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 5, pp. 541-543
Open Access | Times Cited: 951
Showing 1-25 of 951 citing articles:
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 6, pp. 363-374
Open Access | Times Cited: 4293
Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 6, pp. 363-374
Open Access | Times Cited: 4293
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 158-168.e14
Open Access | Times Cited: 1839
Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 158-168.e14
Open Access | Times Cited: 1839
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654
Hematological findings and complications of COVID ‐19
Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Ismaı̈l Elalamy, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 7, pp. 834-847
Open Access | Times Cited: 1626
Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Ismaı̈l Elalamy, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 7, pp. 834-847
Open Access | Times Cited: 1626
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew, Josephine R. Giles, Amy E. Baxter, et al.
Science (2020) Vol. 369, Iss. 6508
Open Access | Times Cited: 1536
Divij Mathew, Josephine R. Giles, Amy E. Baxter, et al.
Science (2020) Vol. 369, Iss. 6508
Open Access | Times Cited: 1536
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, et al.
Nature Medicine (2020) Vol. 26, Iss. 7, pp. 1070-1076
Open Access | Times Cited: 1493
Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, et al.
Nature Medicine (2020) Vol. 26, Iss. 7, pp. 1070-1076
Open Access | Times Cited: 1493
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao, Linlin Bao, Haiyan Mao, et al.
Science (2020) Vol. 369, Iss. 6499, pp. 77-81
Open Access | Times Cited: 1457
Qiang Gao, Linlin Bao, Haiyan Mao, et al.
Science (2020) Vol. 369, Iss. 6499, pp. 77-81
Open Access | Times Cited: 1457
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Ahmet Kürşat Azkur, Mübeccel Akdiş, Dilek Azkur, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1564-1581
Open Access | Times Cited: 1105
Ahmet Kürşat Azkur, Mübeccel Akdiş, Dilek Azkur, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1564-1581
Open Access | Times Cited: 1105
Why does COVID-19 disproportionately affect older people?
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 968
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 968
COVID-19: immunopathogenesis and Immunotherapeutics
Yang Li, Shasha Liu, Jinyan Liu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 836
Yang Li, Shasha Liu, Jinyan Liu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 836
T cell responses in patients with COVID-19
Zeyu Chen, E. John Wherry
Nature reviews. Immunology (2020) Vol. 20, Iss. 9, pp. 529-536
Open Access | Times Cited: 826
Zeyu Chen, E. John Wherry
Nature reviews. Immunology (2020) Vol. 20, Iss. 9, pp. 529-536
Open Access | Times Cited: 826
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
Jeong Seok Lee, Seong-Wan Park, Hye Won Jeong, et al.
Science Immunology (2020) Vol. 5, Iss. 49
Open Access | Times Cited: 813
Jeong Seok Lee, Seong-Wan Park, Hye Won Jeong, et al.
Science Immunology (2020) Vol. 5, Iss. 49
Open Access | Times Cited: 813
Predictors of COVID ‐19 severity: A literature review
Benjamin Gallo Marin, Ghazal Aghagoli, Katya Lavine, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 1, pp. 1-10
Open Access | Times Cited: 748
Benjamin Gallo Marin, Ghazal Aghagoli, Katya Lavine, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 1, pp. 1-10
Open Access | Times Cited: 748
Comprehensive mapping of immune perturbations associated with severe COVID-19
Leticia Kuri-Cervantes, M. Betina Pampena, Wenzhao Meng, et al.
Science Immunology (2020) Vol. 5, Iss. 49
Open Access | Times Cited: 745
Leticia Kuri-Cervantes, M. Betina Pampena, Wenzhao Meng, et al.
Science Immunology (2020) Vol. 5, Iss. 49
Open Access | Times Cited: 745
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
Sara De Biasi, Marianna Meschiari, Lara Gibellini, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 727
Sara De Biasi, Marianna Meschiari, Lara Gibellini, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 727
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 720
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 720
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 651
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 651
Single-cell landscape of immunological responses in patients with COVID-19
Ji‐Yuan Zhang, Xiang‐Ming Wang, Xudong Xing, et al.
Nature Immunology (2020) Vol. 21, Iss. 9, pp. 1107-1118
Open Access | Times Cited: 587
Ji‐Yuan Zhang, Xiang‐Ming Wang, Xudong Xing, et al.
Nature Immunology (2020) Vol. 21, Iss. 9, pp. 1107-1118
Open Access | Times Cited: 587
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 521
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 521
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
Qianwen Zhao, Meng Meng, Rahul Kumar, et al.
International Journal of Infectious Diseases (2020) Vol. 96, pp. 131-135
Open Access | Times Cited: 472
Qianwen Zhao, Meng Meng, Rahul Kumar, et al.
International Journal of Infectious Diseases (2020) Vol. 96, pp. 131-135
Open Access | Times Cited: 472
Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid ‐19)
Yue Zhou, Jingwei Chi, Wenshan Lv, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 2
Open Access | Times Cited: 468
Yue Zhou, Jingwei Chi, Wenshan Lv, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 2
Open Access | Times Cited: 468
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 449
Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 449
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 388
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 388
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19
Joana P. Bernardes, Neha Mishra, Florian Tran, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1296-1314.e9
Open Access | Times Cited: 345
Joana P. Bernardes, Neha Mishra, Florian Tran, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1296-1314.e9
Open Access | Times Cited: 345
Immune-mediated approaches against COVID-19
Helena F. Florindo, Ron Kleiner, Daniella Vaskovich‐Koubi, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 630-645
Open Access | Times Cited: 335
Helena F. Florindo, Ron Kleiner, Daniella Vaskovich‐Koubi, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 630-645
Open Access | Times Cited: 335